NanGenex , a Hungarian company that uses its own technology to synthesize nano-particles, is currently testing a new technology that enhances the absorption of three hypertension therapy drugs and is planning to release it in three years after conducting tests on animals, CEO G�bor Heltovics told MTI Thursday.